Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state
- PMID: 3973412
- DOI: 10.1093/infdis/151.4.599
Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state
Abstract
Yupik Eskimos of southwestern Alaska have the highest known prevalence of hepatitis B virus infection of any general population in the United States. Prospective serological surveys of 1,280 seronegative Yupik Eskimos, performed between 1971 and 1976, identified 189 (14.8%) who developed serological evidence of hepatitis B virus infection. Twenty-six (13.8%) developed clinical hepatitis during the interval when seroconversion occurred. The proportion of patients with clinically apparent hepatitis increased with age (P less than .01), ranging from 9.5% of infections in patients who were four years of age or less to 33.3% of infections in patients who were 30 years of age or older. Twenty-five (13.3%) of the 188 individuals who were studied became chronic carriers of hepatitis B surface antigen. The risk of becoming a carrier was inversely related to the age of the patient at the time of infection (P = .02). Among patients who were four years of age or less when infected, 28.8% became chronic carriers of hepatitis B, as compared with 7.7% of those who were 30 years of age or older.
Similar articles
-
Vasculitis in Eskimos living in an area hyperendemic for hepatitis B.JAMA. 1980 Nov 14;244(19):2180-2. JAMA. 1980. PMID: 7420721
-
Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population.JAMA. 1989 Apr 28;261(16):2362-6. JAMA. 1989. PMID: 2523002
-
Serological markers of hepatitis B infection in Niue children.N Z Med J. 1985 Apr 24;98(777):275-7. N Z Med J. 1985. PMID: 3857507
-
Acute hepatitis A and acquired immunity to hepatitis A virus in hepatitis B virus (HBV) carriers and in HBV- or hepatitis C virus-related chronic liver diseases in Thailand.J Viral Hepat. 2000 May;7 Suppl 1:11-2. doi: 10.1046/j.1365-2893.2000.00017.x. J Viral Hepat. 2000. PMID: 10866839 Review.
-
Hepatitis B and hepatocellular carcinoma in Eskimo/Inuit population.Int J Circumpolar Health. 1998;57 Suppl 1:414-9. Int J Circumpolar Health. 1998. PMID: 10093317 Review.
Cited by
-
Hepatitis B among Inuit: A review with focus on Greenland Inuit.World J Hepatol. 2015 May 28;7(9):1265-71. doi: 10.4254/wjh.v7.i9.1265. World J Hepatol. 2015. PMID: 26019742 Free PMC article. Review.
-
Too much of a good thing? When to stop catch-up vaccination.Med Decis Making. 2013 Oct;33(7):920-36. doi: 10.1177/0272989X13493142. Epub 2013 Jul 15. Med Decis Making. 2013. PMID: 23858015 Free PMC article.
-
[4. Austrian consensus-statement for diagnosis and therapy of hepatitis B 2009].Wien Klin Wochenschr. 2010 May;122(9-10):280-302. doi: 10.1007/s00508-009-1298-0. Epub 2010 May 4. Wien Klin Wochenschr. 2010. PMID: 20443069 German.
-
Model of life expectancy of chronic hepatitis B carriers in an endemic region.J Epidemiol. 2009;19(6):311-8. doi: 10.2188/jea.je20090039. Epub 2009 Oct 3. J Epidemiol. 2009. PMID: 19801886 Free PMC article.
-
Assessment of parasite virulence in a natural population of a planktonic crustacean.BMC Ecol. 2019 Mar 14;19(1):14. doi: 10.1186/s12898-019-0230-3. BMC Ecol. 2019. PMID: 30871516 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical